Acibadem Healthcare Group
Ceyda Çaytemel
Assist. Prof. M.D.

Ceyda Çaytemel

Medical Units and Clinical Services
  • Dermatology

Assist. Prof. Ceyda Çaytemel is a board-certified dermatologist with clinical training completed at Haseki Training and Research Hospital in 2020. She brings practical experience from her role at Acıbadem Health Group beginning in 2022, combining evidence-based dermatologic care with patient-centered practice. Her work focuses on diagnosing and treating a broad range of skin and venereal conditions, applying up-to-date medical approaches and individualized treatment plans. Known for clear communication and compassionate care, she is committed to continuing professional development and delivering high-quality dermatology services.

Education

  • 2020 Haseki Training and Research Hospital Dermatology and Venereology
  • 2015 Bülent Ecevit University Faculty of Medicine

Experience

  • 2022 Acibadem Health Group
  • 2020 – 2022 Istanbul Başakşehir Çam and Sakura City Hospital, Dermatology and Venereal Diseases Clinic, Dermatology Specialist
  • 2016 – 2020 Department of Dermatology and Venereal Diseases, Istanbul Haseki Training and Research Hospital, Assistant Professor
  • 2015 – 2016 Zonguldak Obstetrics and Gynecology Hospital / Doctor

Publications

  • Dermatology outpatient clinic outeomes after COVID-19 outbreak: What is new normal?
    Dermatol Ther. 2021; 34: el4950. Çaytemel C, Erdem O, Ağırgöl Ş, Türkoğlu Z.
  • Case of Olmsted syndrome with essential thrombocytosis misdiagnosed as aerodermatitis enteropathica
    Indian J Dermatol. 2021: 66: 574. Demir FT, Çaytemel C, Caf N, Türkoğlu Z, Ayer M, Büyükbabani N.
  • Pigmented purpuric dermatosis: Ten years of experience in a tertiary hospital and avvareness of mycosis fungoides in differential diagnosis
    J Cutan Pathol. 2021; 48: 611-16. Çaytemel C, Baykut B, Ağırgöl Ş, Caf N, Demir FT, Türkoğlu Z, Uzuner EG.
  • A case of COVID-19 with papulovesicular rash that progressed to retiform purpura, accompanied by eherry angiomas
    Sao Paulo Med J. 2021; 139: 186-89. Agirgol S, Caytemel C, Kolan AŞ, Vural H.
  • Tissue substance P, chymase and angiotensin converting enzyme levels in cold urethral plaques
    Medical Specialization Thesis, 2020, Istanbul. Çaytemel, Ceyda.
  • Dermatologic side effects of targeted antineoplastic therapies: a prospeetive study.
    Cutan Ocul Toxicol. 2020; 39: 380-84. Agirgol S, Caytemel C, Pilanci KN.
  • Systemic isoteretinoin treatment in a renal transplant patient developing sebaceous hyperplasia due to cyclosporine
    North Clin Istanb. 2020; 7: 628-30. Caytemel C, Demir FT, Uzuner EG, Turkoglu Z.
  • Multifactorial painful leg ulcers due to hyperhomocysteinemia, plasminogen activator inhibitor (PAI)- 1 4G/5G heterozygote gene mutation, beta thalassemia minor: A case report.
    Int J Lower Extrem VVounds. 2019; 18: 339-41. Çaytemel C, Topaloglu Demir F, Buyukbabani N, Uzuner EG, Turkoglu Z.
  • Vascular twin kind.
    Am J Med Genet A. 2017; 173: 1919-21. Agirgol S, Ozturk HN, Ozkok Akbulut T, Gunduzoglu C, Turkoglu Z,





×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Contact
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics